Ribociclib and Letrozole Treatment in Ovarian Cancer
Public ClinicalTrials.gov record NCT03673124. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II Trial of Ribociclib (LEE011) Plus Letrozole in Women With Recurrent Low-Grade Serous Carcinoma of the Ovary, Fallopian Tube or Peritoneum
Study identification
- NCT ID
- NCT03673124
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Gynecologic Oncology Group
- Network
- Enrollment
- 51 participants
Conditions and interventions
Conditions
Interventions
- Letrozole Drug
- Ribociclib Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 19, 2019
- Primary completion
- Dec 22, 2024
- Completion
- Dec 30, 2026
- Last update posted
- Dec 22, 2025
2019 – 2026
United States locations
- U.S. sites
- 27
- U.S. states
- 15
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of California, San Francisco | San Francisco | California | 94158 | — |
| UF Heath | Gainesville | Florida | 32610 | — |
| Moffitt Cancer Center | Tampa | Florida | 33612 | — |
| Northside Hospital | Atlanta | Georgia | 30342 | — |
| NorthShore University HealthSystem | Evanston | Illinois | 60201 | — |
| Saint Vincent Hospital and Health Care Center, Inc. | Indianapolis | Indiana | 46260 | — |
| St. Joseph Mercy Hospital Cancer Care Center | Ann Arbor | Michigan | 48106 | — |
| Mayo Clinic - Rochester | Rochester | Minnesota | 55905 | — |
| Dartmouth-Hitchcock Medical Center | Lebanon | New Hampshire | 05055 | — |
| Hackensack University Medical Center | Hackensack | New Jersey | 07601 | — |
| The Valley Hospital Inc. | Ridgewood | New Jersey | 07540 | — |
| New Mexico Cancer Care Alliance/University of New Mexico Comprehensive Cancer Center | Albuquerque | New Mexico | 87008 | — |
| Southwest Gynecologic Oncology Associates | Albuquerque | New Mexico | 87008 | — |
| Miami Valley Hospital | Centerville | Ohio | 45459 | — |
| The Ohio State Comprehensive Cancer Center | Columbus | Ohio | 43210 | — |
| University of Oklahoma Health Sciences Center | Oklahoma City | Oklahoma | 73104 | — |
| Oklahoma Cancer Care Specialists and Research Institute , LLC | Tulsa | Oklahoma | 74146 | — |
| Western Pennsylvania Hospital/West Penn Hospital | Pittsburgh | Pennsylvania | 15224 | — |
| Abington Memorial Hospital | Willow Grove | Pennsylvania | 19090 | — |
| Women & Infants Hospital | Providence | Rhode Island | 02905 | — |
| Parkland Health and Hospital System | Dallas | Texas | 75235 | — |
| University of Texas Southwestern Medical Center | Dallas | Texas | 75390 | — |
| MD Anderson Cancer Center | Houston | Texas | 77030 | — |
| Memorial Hermann Texas Medical Center - Texas Medical Center | Houston | Texas | 77030 | — |
| Houston Methodist Willowbrook Hospital | Houston | Texas | 77070 | — |
| Houston Methodist Hospital | Houston | Texas | 77479 | — |
| Houston Methodist Sugar Land Hospital | Sugar Land | Texas | 77479 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03673124, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 22, 2025 · Synced May 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03673124 live on ClinicalTrials.gov.